Erleada 240 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB26FXHKP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,705
Award facts
- Contract value 100% obligated
- $14,705.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $14,705 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ERLEADA 240 mg tablets (30-count units) on November 5, 2025, with completion scheduled for November 28, 2025. The award was competitively issued with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999 ceiling value through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's comprehensive federal contracting portfolio encompasses a wide range of pharmaceutical products, medical devices, and healthcare commodities across multiple therapeutic domains. Through its DLA Troop Support Medical prime contract vehicle, AmerisourceBergen supplies pharmaceutical products globally to support military healthcare programs, serving customers including the Defense Health Agency and U.S. Coast Guard. This contract award exemplifies the company's capability to fulfill federal medical supply requirements through competitive procurement processes and demonstrates its role as a primary pharmaceutical vendor within the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DB26FXHKP?
SPE2DB26FXHKP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DB26FXHKP worth?
The government has obligated $14,705 on SPE2DB26FXHKP.
Is contract SPE2DB26FXHKP an order under another contract?
Yes. SPE2DB26FXHKP is a delivery order under SPE2DB25D3006, an indefinite delivery contract.
Was contract SPE2DB26FXHKP competed?
The extent of competition for SPE2DB26FXHKP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award